Skip to main content

Peer Review reports

From: MiR-659-3p inhibits osteosarcoma progression and metastasis by inhibiting cell proliferation and invasion via targeting SRPK1

Original Submission
15 Dec 2021 Submitted Original manuscript
2 Jan 2022 Reviewed Reviewer Report - Ankita Srivastava
2 Jan 2022 Reviewed Reviewer Report - Mohammad Asif Sherwani
9 Jan 2022 Reviewed Reviewer Report
15 Mar 2022 Author responded Author comments - Yubao Gong
Resubmission - Version 2
15 Mar 2022 Submitted Manuscript version 2
21 Jul 2022 Author responded Author comments - Yubao Gong
Resubmission - Version 3
21 Jul 2022 Submitted Manuscript version 3
30 Jul 2022 Author responded Author comments - Yubao Gong
Resubmission - Version 4
30 Jul 2022 Submitted Manuscript version 4
2 Aug 2022 Reviewed Reviewer Report - Mohammad Asif Sherwani
10 Aug 2022 Reviewed Reviewer Report - Ankita Srivastava
20 Aug 2022 Reviewed Reviewer Report
Resubmission - Version 5
Submitted Manuscript version 5
Publishing
24 Aug 2022 Editorially accepted
29 Aug 2022 Article published 10.1186/s12885-022-10029-0

You can find further information about peer review here.

Back to article page